Currently, the country’s first indigenous corona vaccine, Covaxin, is undergoing human trials in various states of the country.
Kovaxin, the country’s first indigenous corona vaccine, is currently undergoing human trials in various states. The first part of the first phase of human trials of Covaxin at the Post-Graduate Institute of Medical Sciences (PGI), Rohtak, Haryana, has been completed.
Now the preparation for the second part has started here.
Six people were vaccinated on Saturday under the second part of the first phase. Speaking to ANI, the Chief Investigator of the Vaccine Trial Team, Dr. Savita Verma said that the first part of the first phase of the vaccine trial has been completed. The vaccine was given to 50 people across India and the results were encouraging.
The first phase of the trial is going on in Delhi AIIMS
Human trials of the country’s first corona vaccine in collaboration with ICMR and Bharat Biotech are underway at AIIMS in Delhi. Phase I clinical trials are currently underway at AIIMS, Delhi.
Five people were vaccinated with the Corona vaccine on Saturday, the second day after human trials began. In AIIMS, 100 people are to be tested in the first phase. A 30-year-old youth was vaccinated when the trial began on Friday. So far six people have been vaccinated.
Human trials started in Patna AIIMS
The vaccine designed to protect against the coronavirus has started at the All India Institute of Medical Sciences (AIIMS) in Patna from 16 July. For this, 20 patients including five AIIMS personnel have come forward as Corona warriors.
The results of human trials will be revealed in the next 194 days.
Corona vaccine trial will start soon in Gorakhpur
Preparations for the trial of the Corona vaccine have started in Gorakhpur. Rana Hospital has started searching for volunteers soon after Bharat Biotech and ICMR agreed to send the vaccine.
According to hospital administration, the vaccine will be made available for testing in a maximum of five days.
The vaccine is expected to develop by the end of the year
The Serum Institute of India hopes to develop the vaccine by the end of this year. Serum Institute CEO Adar Poonawala said that we are currently working on the AstraZeneca Oxford vaccine. The third phase of this is undergoing clinical trials.
Pre-clinical trial phase inoculation
It will be launched in India in August 2020. Based on the current results, we expect the vaccine to be available by the end of this year. The Pakiram Institute is also working on a vaccine in collaboration with US-based biotech firm Codegenics. The vaccine is in its pre-clinical trial phase.
7 Indian companies involved in making Corona vaccine
Seven Indian pharma companies are currently manufacturing vaccines against the coronavirus. These include Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotech, Indian Immunological, Minwax, and Biology e.